Washington, D.C. VAMC

Washington D.C., District of Columbia 20422

1 studies enrolling now · 15 studies all time

What they study most

Alcoholism, CRPC, Deep Venous Thrombosis, HIV, HIV Infections, Heart Failure, Hepatitis C, Liver Diseases, Alcoholic, Multiple Sclerosis, Myocardial Infarction, Prostate Cancer, Prostate Cancer Metastatic

Studies at this site

• Castrate Resistant Prostate Cancer Enhertu Therapy — Recruiting now
• A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE — Stopped early
• A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE — Stopped early
• Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection — Completed
• Integrated Stepped Care for Unhealthy Alcohol Use in HIV — Completed
• INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure — Completed
• Home Exercise Telerehabiliation for MS — Completed
• TBTC Study 23C: Pharmacokinetics of Intermittent Rifabutin and Isoniazid With Daily Efavirenz — Completed
• TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance — Completed
• TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis — Completed
• TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB — Completed
• TBTC Study 25PK: Intensive Pharmacokinetic Study of Three Doses of Rifapentine and 25-Desacetyl Rifapentine — Completed
• TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis — Completed
• TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB — Completed
• TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen — Completed